DCM
CNMD icon

Dean Capital Management’s CONMED CNMD Stock Holding History

Dean Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,301
Closed -$702K – 114
2025
Q4 		$702K Buy
17,301
+67
+0.4% +$2.92K 0.3% 107
2025
Q3 		$811K Sell
17,234
-5,224
-23% -$271K 0.32% 114
2025
Q2 		$1.17M Sell
22,458
-6,845
-23% -$376K 0.48% 112
2025
Q1 		$1.77M Buy
29,303
+3,728
+15% +$240K 0.77% 54
2024
Q4 		$1.75M Buy
25,575
+10,019
+64% +$698K 0.75% 61
2024
Q3 		$1.12M Buy
15,556
+5,683
+58% +$401K 0.48% 116
2024
Q2 		$684K Buy
+9,873
New +$720K 0.88% 49

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Dean Capital Management's CNMD Position: Q1 2026 in Review

Dean Capital Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 17,301 shares — an estimated $702K sold.

Dean Capital Management first reported a position in CNMD in Q2 2024 and held it in 7 quarters. The position peaked at $1.77M in Q1 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Dean Capital Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Dean Capital Management sold 17,301 CONMED shares in Q1 2026, an estimated $702K.
  • Dean Capital Management first reported a position in CONMED in Q2 2024 and held it in 7 quarters.
  • Dean Capital Management's CONMED position peaked at $1.77M in Q1 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Dean Capital Management's 13F filing for Q1 2026, filed 15 May 2026.